Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of B cell apoptotic process (GO:0002903) | 6.17353308 |
2 | immunoglobulin mediated immune response (GO:0016064) | 5.09231672 |
3 | DNA deamination (GO:0045006) | 4.80003095 |
4 | regulation of B cell apoptotic process (GO:0002902) | 4.60753843 |
5 | B cell mediated immunity (GO:0019724) | 4.50993614 |
6 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.20346226 |
7 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.03583501 |
8 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.03404815 |
9 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.00529374 |
10 | purine nucleotide salvage (GO:0032261) | 3.93128984 |
11 | pseudouridine synthesis (GO:0001522) | 3.89738239 |
12 | deoxyribonucleotide catabolic process (GO:0009264) | 3.82886322 |
13 | interferon-gamma secretion (GO:0072643) | 3.79331914 |
14 | fucose catabolic process (GO:0019317) | 3.72672889 |
15 | L-fucose metabolic process (GO:0042354) | 3.72672889 |
16 | L-fucose catabolic process (GO:0042355) | 3.72672889 |
17 | deoxyribose phosphate catabolic process (GO:0046386) | 3.65526083 |
18 | thrombin receptor signaling pathway (GO:0070493) | 3.64736907 |
19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.47767124 |
20 | nucleotide salvage (GO:0043173) | 3.43617776 |
21 | rRNA modification (GO:0000154) | 3.39977476 |
22 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37685563 |
23 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.23245380 |
24 | histone H2A acetylation (GO:0043968) | 3.20601764 |
25 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.10007463 |
26 | telomere maintenance via telomere lengthening (GO:0010833) | 3.08144570 |
27 | regulation of antigen processing and presentation (GO:0002577) | 3.05634079 |
28 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.03274428 |
29 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.98962348 |
30 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.98469709 |
31 | mature B cell differentiation involved in immune response (GO:0002313) | 2.96667761 |
32 | DNA replication checkpoint (GO:0000076) | 2.96102829 |
33 | DNA strand elongation (GO:0022616) | 2.94518496 |
34 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.93772351 |
35 | positive thymic T cell selection (GO:0045059) | 2.93566820 |
36 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.93500183 |
37 | dosage compensation (GO:0007549) | 2.92028979 |
38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91169849 |
39 | telomere maintenance via recombination (GO:0000722) | 2.88860478 |
40 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.87383843 |
41 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.85132641 |
42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83727754 |
43 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.82580907 |
44 | autophagic vacuole fusion (GO:0000046) | 2.81491547 |
45 | rRNA methylation (GO:0031167) | 2.81149986 |
46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.80764149 |
47 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.79426323 |
48 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.79426323 |
49 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.78337238 |
50 | deoxyribose phosphate metabolic process (GO:0019692) | 2.77328695 |
51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74411396 |
52 | protein neddylation (GO:0045116) | 2.74005850 |
53 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.71507388 |
54 | negative thymic T cell selection (GO:0045060) | 2.71015823 |
55 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.69543757 |
56 | tryptophan metabolic process (GO:0006568) | 2.67335958 |
57 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.66787030 |
58 | negative T cell selection (GO:0043383) | 2.65779130 |
59 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.64316622 |
60 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.63571216 |
61 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.63338882 |
62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.62957131 |
63 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.62012803 |
64 | inositol phosphate dephosphorylation (GO:0046855) | 2.62012803 |
65 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.61838514 |
66 | base-excision repair, AP site formation (GO:0006285) | 2.60381938 |
67 | negative regulation of mRNA processing (GO:0050686) | 2.60288381 |
68 | proteasome assembly (GO:0043248) | 2.59072972 |
69 | deoxyribonucleotide metabolic process (GO:0009262) | 2.58789744 |
70 | purine-containing compound salvage (GO:0043101) | 2.57801489 |
71 | mitotic recombination (GO:0006312) | 2.56803358 |
72 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.56729409 |
73 | tRNA modification (GO:0006400) | 2.56320719 |
74 | negative regulation of ligase activity (GO:0051352) | 2.54259524 |
75 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.54259524 |
76 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.52698405 |
77 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.52532532 |
78 | cullin deneddylation (GO:0010388) | 2.52375890 |
79 | tRNA processing (GO:0008033) | 2.52206055 |
80 | glutathione biosynthetic process (GO:0006750) | 2.51688533 |
81 | platelet dense granule organization (GO:0060155) | 2.50444461 |
82 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.49710454 |
83 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.48704225 |
84 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.48171857 |
85 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.43323363 |
86 | replication fork processing (GO:0031297) | 2.41929392 |
87 | mannosylation (GO:0097502) | 2.41284500 |
88 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.41156224 |
89 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.41156224 |
90 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.41138905 |
91 | innate immune response in mucosa (GO:0002227) | 2.40708531 |
92 | fucose metabolic process (GO:0006004) | 2.40365016 |
93 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.40202515 |
94 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.40202515 |
95 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.40202515 |
96 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.39978156 |
97 | organelle membrane fusion (GO:0090174) | 2.39321709 |
98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.38672802 |
99 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.38064923 |
100 | regulation of thymocyte apoptotic process (GO:0070243) | 2.37886326 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.67809172 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.17107283 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.09584692 |
4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.79639709 |
5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.76101919 |
6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.58051383 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.56650773 |
8 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41694624 |
9 | MYC_22102868_ChIP-Seq_BL_Human | 2.32141212 |
10 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.28594532 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.25192407 |
12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.24690885 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22249211 |
14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18679897 |
15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14562909 |
16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.10411134 |
17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.08449123 |
18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.08080057 |
19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06284042 |
20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00813447 |
21 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.00295655 |
22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98122182 |
23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98080558 |
24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97732687 |
25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.97520062 |
26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.91014353 |
27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90103310 |
28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89646294 |
29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86823201 |
30 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.84550416 |
31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.83461195 |
32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.81265905 |
33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.79894102 |
34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.76635862 |
35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.74113887 |
36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70168735 |
37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.69391668 |
38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.69334963 |
39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68163354 |
40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67656333 |
41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.66047503 |
42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.65500603 |
43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.65205210 |
44 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.62780005 |
45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60654322 |
46 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58129901 |
47 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55996643 |
48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55439014 |
49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54126908 |
50 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.52114177 |
51 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.51630398 |
52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.51218769 |
53 | MAF_26560356_Chip-Seq_TH1_Human | 1.50062089 |
54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49392009 |
55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47905594 |
56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.47873698 |
57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47339762 |
58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45717874 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45241094 |
60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44683158 |
61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.43381748 |
62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43193221 |
63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42456885 |
64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41072857 |
65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.38751643 |
66 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.37949841 |
67 | MAF_26560356_Chip-Seq_TH2_Human | 1.36045799 |
68 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34796967 |
69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34029425 |
70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.33584416 |
71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32764999 |
72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32316848 |
73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31873833 |
74 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30183333 |
75 | P68_20966046_ChIP-Seq_HELA_Human | 1.28668329 |
76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28045641 |
77 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.28000097 |
78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22414517 |
79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22367123 |
80 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21518886 |
81 | MYB_26560356_Chip-Seq_TH2_Human | 1.21179928 |
82 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21156819 |
83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19368648 |
84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19198710 |
85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19061657 |
86 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18683758 |
87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16182699 |
88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13066553 |
89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12324840 |
90 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11509746 |
91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10812930 |
92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10362695 |
93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10179942 |
94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08940225 |
95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08774321 |
96 | MYB_26560356_Chip-Seq_TH1_Human | 1.08537114 |
97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07613265 |
98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06761538 |
99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06728605 |
100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06694612 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.99471109 |
2 | MP0003111_abnormal_nucleus_morphology | 3.41805233 |
3 | MP0003693_abnormal_embryo_hatching | 3.29243584 |
4 | MP0009697_abnormal_copulation | 3.12695783 |
5 | MP0010094_abnormal_chromosome_stability | 2.94157814 |
6 | MP0009278_abnormal_bone_marrow | 2.87600055 |
7 | MP0005464_abnormal_platelet_physiology | 2.75924349 |
8 | MP0002396_abnormal_hematopoietic_system | 2.75000181 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.64009376 |
10 | MP0002138_abnormal_hepatobiliary_system | 2.57097838 |
11 | MP0005075_abnormal_melanosome_morpholog | 2.35873562 |
12 | MP0005397_hematopoietic_system_phenotyp | 2.26102500 |
13 | MP0001545_abnormal_hematopoietic_system | 2.26102500 |
14 | MP0000685_abnormal_immune_system | 2.21477987 |
15 | MP0005645_abnormal_hypothalamus_physiol | 2.21460157 |
16 | MP0002166_altered_tumor_susceptibility | 2.20496248 |
17 | MP0000465_gastrointestinal_hemorrhage | 2.17485135 |
18 | MP0003077_abnormal_cell_cycle | 2.16032091 |
19 | MP0005000_abnormal_immune_tolerance | 2.05731273 |
20 | MP0002398_abnormal_bone_marrow | 2.03321723 |
21 | MP0008058_abnormal_DNA_repair | 2.01160840 |
22 | MP0001800_abnormal_humoral_immune | 1.89830653 |
23 | MP0004957_abnormal_blastocyst_morpholog | 1.88041975 |
24 | MP0002019_abnormal_tumor_incidence | 1.85674929 |
25 | MP0003303_peritoneal_inflammation | 1.80677098 |
26 | MP0002006_tumorigenesis | 1.80276531 |
27 | MP0002452_abnormal_antigen_presenting | 1.77534825 |
28 | MP0005671_abnormal_response_to | 1.76005287 |
29 | MP0002148_abnormal_hypersensitivity_rea | 1.75510187 |
30 | MP0004808_abnormal_hematopoietic_stem | 1.71444906 |
31 | MP0006036_abnormal_mitochondrial_physio | 1.70324854 |
32 | MP0002420_abnormal_adaptive_immunity | 1.70216512 |
33 | MP0003724_increased_susceptibility_to | 1.69661701 |
34 | MP0003436_decreased_susceptibility_to | 1.68582018 |
35 | MP0001819_abnormal_immune_cell | 1.67802919 |
36 | MP0002723_abnormal_immune_serum | 1.66408884 |
37 | MP0000689_abnormal_spleen_morphology | 1.64465716 |
38 | MP0002429_abnormal_blood_cell | 1.61872966 |
39 | MP0008007_abnormal_cellular_replicative | 1.60036360 |
40 | MP0002722_abnormal_immune_system | 1.59357880 |
41 | MP0000716_abnormal_immune_system | 1.59201436 |
42 | MP0001790_abnormal_immune_system | 1.56948402 |
43 | MP0005387_immune_system_phenotype | 1.56948402 |
44 | MP0005025_abnormal_response_to | 1.54183991 |
45 | MP0005058_abnormal_lysosome_morphology | 1.53144453 |
46 | MP0003718_maternal_effect | 1.52541131 |
47 | MP0009785_altered_susceptibility_to | 1.49654452 |
48 | MP0008961_abnormal_basal_metabolism | 1.44683847 |
49 | MP0009333_abnormal_splenocyte_physiolog | 1.41775093 |
50 | MP0008872_abnormal_physiological_respon | 1.38885644 |
51 | MP0003763_abnormal_thymus_physiology | 1.36750027 |
52 | MP0002405_respiratory_system_inflammati | 1.35982324 |
53 | MP0001873_stomach_inflammation | 1.35838282 |
54 | MP0002419_abnormal_innate_immunity | 1.33761061 |
55 | MP0008995_early_reproductive_senescence | 1.32930933 |
56 | MP0000703_abnormal_thymus_morphology | 1.32349052 |
57 | MP0000490_abnormal_crypts_of | 1.29108660 |
58 | MP0008932_abnormal_embryonic_tissue | 1.26931813 |
59 | MP0003252_abnormal_bile_duct | 1.24729887 |
60 | MP0000313_abnormal_cell_death | 1.22389447 |
61 | MP0003786_premature_aging | 1.20546683 |
62 | MP0005220_abnormal_exocrine_pancreas | 1.19917861 |
63 | MP0010155_abnormal_intestine_physiology | 1.17692918 |
64 | MP0010307_abnormal_tumor_latency | 1.15594862 |
65 | MP0001845_abnormal_inflammatory_respons | 1.10701423 |
66 | MP0005084_abnormal_gallbladder_morpholo | 1.05951969 |
67 | MP0003172_abnormal_lysosome_physiology | 1.05483426 |
68 | MP0004381_abnormal_hair_follicle | 1.00262552 |
69 | MP0008057_abnormal_DNA_replication | 0.98952333 |
70 | MP0009764_decreased_sensitivity_to | 0.98863590 |
71 | MP0005451_abnormal_body_composition | 0.97715982 |
72 | MP0001853_heart_inflammation | 0.97361286 |
73 | MP0006035_abnormal_mitochondrial_morpho | 0.96196728 |
74 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94192996 |
75 | MP0005410_abnormal_fertilization | 0.92435671 |
76 | MP0000350_abnormal_cell_proliferation | 0.88229789 |
77 | MP0000358_abnormal_cell_content/ | 0.86465853 |
78 | MP0002089_abnormal_postnatal_growth/wei | 0.84446907 |
79 | MP0005501_abnormal_skin_physiology | 0.80920269 |
80 | MP0002332_abnormal_exercise_endurance | 0.78053835 |
81 | MP0008469_abnormal_protein_level | 0.77729026 |
82 | MP0002132_abnormal_respiratory_system | 0.76594344 |
83 | MP0008873_increased_physiological_sensi | 0.76046344 |
84 | MP0000858_altered_metastatic_potential | 0.75887502 |
85 | MP0003866_abnormal_defecation | 0.75700586 |
86 | MP0001764_abnormal_homeostasis | 0.73064890 |
87 | MP0000015_abnormal_ear_pigmentation | 0.69261299 |
88 | MP0002080_prenatal_lethality | 0.67062411 |
89 | MP0004947_skin_inflammation | 0.66157022 |
90 | MP0001730_embryonic_growth_arrest | 0.65191155 |
91 | MP0001663_abnormal_digestive_system | 0.64395163 |
92 | MP0001533_abnormal_skeleton_physiology | 0.63696717 |
93 | MP0009763_increased_sensitivity_to | 0.63430427 |
94 | MP0004233_abnormal_muscle_weight | 0.62601906 |
95 | MP0005266_abnormal_metabolism | 0.62319447 |
96 | MP0005621_abnormal_cell_physiology | 0.62095319 |
97 | MP0003191_abnormal_cellular_cholesterol | 0.61310653 |
98 | MP0003186_abnormal_redox_activity | 0.60632906 |
99 | MP0005384_cellular_phenotype | 0.59472926 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.58934685 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prostate neoplasm (HP:0100787) | 4.04326907 |
2 | Abnormality of B cell number (HP:0010975) | 3.72467864 |
3 | Petechiae (HP:0000967) | 3.69139846 |
4 | Abnormality of the prostate (HP:0008775) | 3.52095344 |
5 | B lymphocytopenia (HP:0010976) | 3.48671321 |
6 | Hypomagnesemia (HP:0002917) | 3.45081038 |
7 | Agammaglobulinemia (HP:0004432) | 3.37026627 |
8 | Aplastic anemia (HP:0001915) | 3.33467281 |
9 | Microvesicular hepatic steatosis (HP:0001414) | 3.29657580 |
10 | Abnormal number of erythroid precursors (HP:0012131) | 3.23488418 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.19466382 |
12 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.17503470 |
13 | Panhypogammaglobulinemia (HP:0003139) | 3.17501597 |
14 | Hyperacusis (HP:0010780) | 3.08407921 |
15 | Abnormality of lateral ventricle (HP:0030047) | 2.98872829 |
16 | Prolonged bleeding time (HP:0003010) | 2.98012837 |
17 | Abnormality of magnesium homeostasis (HP:0004921) | 2.94483434 |
18 | Recurrent fungal infections (HP:0002841) | 2.87106174 |
19 | Overriding aorta (HP:0002623) | 2.75607598 |
20 | Elfin facies (HP:0004428) | 2.75466429 |
21 | Cellulitis (HP:0100658) | 2.64170166 |
22 | Increased serum lactate (HP:0002151) | 2.63162385 |
23 | Myelodysplasia (HP:0002863) | 2.62875947 |
24 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.62577083 |
25 | Progressive muscle weakness (HP:0003323) | 2.61663484 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61558932 |
27 | Obstructive lung disease (HP:0006536) | 2.61558932 |
28 | Epistaxis (HP:0000421) | 2.61201644 |
29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56303202 |
30 | Mesangial abnormality (HP:0001966) | 2.53398484 |
31 | Hypertensive crisis (HP:0100735) | 2.52090618 |
32 | Acute lymphatic leukemia (HP:0006721) | 2.50625839 |
33 | Dyschromatopsia (HP:0007641) | 2.50154856 |
34 | Increased intramyocellular lipid droplets (HP:0012240) | 2.48954187 |
35 | Absent thumb (HP:0009777) | 2.48951308 |
36 | Dicarboxylic aciduria (HP:0003215) | 2.48633380 |
37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48633380 |
38 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.47982945 |
39 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.43973247 |
40 | Hepatocellular necrosis (HP:0001404) | 2.43655406 |
41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41499356 |
42 | Squamous cell carcinoma (HP:0002860) | 2.40932348 |
43 | Abnormality of the carotid arteries (HP:0005344) | 2.40545105 |
44 | Meningitis (HP:0001287) | 2.38330397 |
45 | Recurrent viral infections (HP:0004429) | 2.36337808 |
46 | Hepatic necrosis (HP:0002605) | 2.34469049 |
47 | Absent epiphyses (HP:0010577) | 2.33369150 |
48 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.33369150 |
49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33154607 |
50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33154607 |
51 | Abnormality of T cell physiology (HP:0011840) | 2.30463905 |
52 | Testicular atrophy (HP:0000029) | 2.30251691 |
53 | Increased muscle lipid content (HP:0009058) | 2.29758405 |
54 | Abnormality of male internal genitalia (HP:0000022) | 2.29745781 |
55 | Autoimmune thrombocytopenia (HP:0001973) | 2.27175754 |
56 | Autoimmune hemolytic anemia (HP:0001890) | 2.26806680 |
57 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.23951462 |
58 | Mediastinal lymphadenopathy (HP:0100721) | 2.19933205 |
59 | Increased serum ferritin (HP:0003281) | 2.17721392 |
60 | Birth length less than 3rd percentile (HP:0003561) | 2.17080521 |
61 | Acute necrotizing encephalopathy (HP:0006965) | 2.16949927 |
62 | Delayed CNS myelination (HP:0002188) | 2.15501047 |
63 | Severe combined immunodeficiency (HP:0004430) | 2.15224943 |
64 | Abnormality of the preputium (HP:0100587) | 2.13526887 |
65 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.12020585 |
66 | Flat cornea (HP:0007720) | 2.06864328 |
67 | Granulocytopenia (HP:0001913) | 2.06119476 |
68 | Prominent nose (HP:0000448) | 2.05475754 |
69 | Abnormality of T cells (HP:0002843) | 2.05256987 |
70 | Mitochondrial inheritance (HP:0001427) | 2.04857999 |
71 | Progressive microcephaly (HP:0000253) | 2.01442490 |
72 | Bone marrow hypocellularity (HP:0005528) | 2.00946647 |
73 | Pulmonary fibrosis (HP:0002206) | 1.97948457 |
74 | Lactic acidosis (HP:0003128) | 1.96883621 |
75 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.96227136 |
76 | Renovascular hypertension (HP:0100817) | 1.94225925 |
77 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.93489704 |
78 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.93489704 |
79 | Increased CSF lactate (HP:0002490) | 1.93458136 |
80 | Poor head control (HP:0002421) | 1.93079227 |
81 | Large eyes (HP:0001090) | 1.92541361 |
82 | Attenuation of retinal blood vessels (HP:0007843) | 1.91982266 |
83 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91089637 |
84 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90476746 |
85 | Insomnia (HP:0100785) | 1.89180200 |
86 | Hypercalciuria (HP:0002150) | 1.88273163 |
87 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.86682150 |
88 | Encephalitis (HP:0002383) | 1.86081296 |
89 | Increased IgE level (HP:0003212) | 1.84020073 |
90 | Type I transferrin isoform profile (HP:0003642) | 1.81566476 |
91 | Microretrognathia (HP:0000308) | 1.81316752 |
92 | J-shaped sella turcica (HP:0002680) | 1.81195663 |
93 | Chromsome breakage (HP:0040012) | 1.80109792 |
94 | Combined immunodeficiency (HP:0005387) | 1.79111567 |
95 | Abnormality of iron homeostasis (HP:0011031) | 1.78861254 |
96 | Chest pain (HP:0100749) | 1.78837213 |
97 | Clubbing of toes (HP:0100760) | 1.78448909 |
98 | Pancytopenia (HP:0001876) | 1.78272275 |
99 | Exercise intolerance (HP:0003546) | 1.77962008 |
100 | Renal Fanconi syndrome (HP:0001994) | 1.76843773 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ZAK | 4.92632296 |
2 | TLK1 | 4.69908458 |
3 | SCYL2 | 4.17765499 |
4 | ERN1 | 3.19600023 |
5 | BUB1 | 2.83722086 |
6 | MAP4K1 | 2.64854697 |
7 | KIT | 2.53010924 |
8 | BCKDK | 2.22001120 |
9 | KDR | 2.10048403 |
10 | NUAK1 | 2.09398085 |
11 | MST4 | 2.08624260 |
12 | TAOK3 | 2.07473091 |
13 | TESK2 | 1.95077283 |
14 | CDK12 | 1.91888935 |
15 | NME2 | 1.89081573 |
16 | SIK3 | 1.85064478 |
17 | STK4 | 1.84150888 |
18 | VRK1 | 1.80016087 |
19 | VRK2 | 1.70563831 |
20 | TBK1 | 1.60492776 |
21 | CDK8 | 1.59557111 |
22 | CDC7 | 1.46810222 |
23 | ATR | 1.37958264 |
24 | PIM2 | 1.37577831 |
25 | FLT3 | 1.37520113 |
26 | MAP4K2 | 1.36869222 |
27 | IKBKB | 1.34524045 |
28 | CSF1R | 1.25859985 |
29 | STK16 | 1.22418565 |
30 | SYK | 1.22185415 |
31 | MAP2K3 | 1.20016829 |
32 | PBK | 1.19049508 |
33 | EIF2AK1 | 1.17050184 |
34 | RPS6KA5 | 1.16359345 |
35 | MAP3K14 | 1.15361515 |
36 | IKBKE | 1.11700398 |
37 | IRAK4 | 1.11641981 |
38 | SMG1 | 1.11590114 |
39 | FER | 1.03690362 |
40 | GRK6 | 1.02445045 |
41 | CDK9 | 0.96928729 |
42 | AURKA | 0.95177690 |
43 | SIK1 | 0.92657095 |
44 | MAP3K3 | 0.90336646 |
45 | MAP3K8 | 0.90334046 |
46 | MAPK11 | 0.89320109 |
47 | JAK3 | 0.84534166 |
48 | CDK4 | 0.83402060 |
49 | CCNB1 | 0.83365327 |
50 | IRAK3 | 0.82038915 |
51 | AURKB | 0.81320354 |
52 | BTK | 0.80038386 |
53 | CHEK2 | 0.78913371 |
54 | SIK2 | 0.77129542 |
55 | FES | 0.75937577 |
56 | SRPK1 | 0.74821386 |
57 | MAPKAPK3 | 0.73691855 |
58 | DYRK3 | 0.72433442 |
59 | LYN | 0.71324129 |
60 | BMX | 0.70381193 |
61 | PIM1 | 0.69745638 |
62 | IRAK2 | 0.68202623 |
63 | CDK7 | 0.66891529 |
64 | PLK1 | 0.66164036 |
65 | RPS6KB2 | 0.64668819 |
66 | RPS6KA4 | 0.62638691 |
67 | MAP3K13 | 0.61756754 |
68 | MAP3K11 | 0.61485260 |
69 | BLK | 0.56037619 |
70 | MARK3 | 0.55269917 |
71 | DAPK1 | 0.53140214 |
72 | CHEK1 | 0.50057207 |
73 | TRIM28 | 0.49947818 |
74 | STK10 | 0.48567918 |
75 | PLK4 | 0.48142753 |
76 | CHUK | 0.47708168 |
77 | MAP2K2 | 0.46491400 |
78 | TNK2 | 0.46023645 |
79 | TEC | 0.45676804 |
80 | TTK | 0.43754189 |
81 | PRKCI | 0.42149219 |
82 | RIPK4 | 0.42042681 |
83 | HIPK2 | 0.41130657 |
84 | EIF2AK3 | 0.40332332 |
85 | AKT2 | 0.37768106 |
86 | IRAK1 | 0.37246623 |
87 | DAPK3 | 0.34036696 |
88 | BMPR1B | 0.32482207 |
89 | ATM | 0.32200804 |
90 | PRKCQ | 0.31214180 |
91 | MATK | 0.30026590 |
92 | MAP3K1 | 0.29256903 |
93 | EIF2AK2 | 0.29098383 |
94 | PKN2 | 0.28614604 |
95 | MAPKAPK2 | 0.28586275 |
96 | CDK2 | 0.25266389 |
97 | MAP3K2 | 0.24866942 |
98 | ARAF | 0.24089178 |
99 | DYRK1B | 0.23935127 |
100 | PAK1 | 0.22970814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.27701047 |
2 | Asthma_Homo sapiens_hsa05310 | 3.77526487 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 3.47702061 |
4 | DNA replication_Homo sapiens_hsa03030 | 3.26373031 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.09939233 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.08519928 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.95973768 |
8 | Proteasome_Homo sapiens_hsa03050 | 2.70295555 |
9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.62845664 |
10 | Mismatch repair_Homo sapiens_hsa03430 | 2.45588358 |
11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.39280626 |
12 | Alcoholism_Homo sapiens_hsa05034 | 2.26710305 |
13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.16876604 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11135692 |
15 | Base excision repair_Homo sapiens_hsa03410 | 2.04370941 |
16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92598438 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91589565 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86600595 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84193169 |
20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83397390 |
21 | RNA polymerase_Homo sapiens_hsa03020 | 1.78488635 |
22 | Homologous recombination_Homo sapiens_hsa03440 | 1.70213764 |
23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.61154113 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59067811 |
25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.56843495 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56210700 |
27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.54570681 |
28 | Spliceosome_Homo sapiens_hsa03040 | 1.44888351 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43902987 |
30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.37991033 |
31 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.35446314 |
32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21087623 |
33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18825730 |
34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16719115 |
35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16634187 |
36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.13985481 |
37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13656204 |
38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13238775 |
39 | Cell cycle_Homo sapiens_hsa04110 | 1.10821749 |
40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03212994 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01650877 |
42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00591371 |
43 | Purine metabolism_Homo sapiens_hsa00230 | 0.99540554 |
44 | RNA degradation_Homo sapiens_hsa03018 | 0.98954200 |
45 | RNA transport_Homo sapiens_hsa03013 | 0.96579125 |
46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90883376 |
47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88615662 |
48 | Tuberculosis_Homo sapiens_hsa05152 | 0.88058000 |
49 | Influenza A_Homo sapiens_hsa05164 | 0.87231166 |
50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83049237 |
51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.81745386 |
52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79210772 |
53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73151059 |
54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69497438 |
55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66303380 |
56 | Ribosome_Homo sapiens_hsa03010 | 0.61355842 |
57 | Platelet activation_Homo sapiens_hsa04611 | 0.58002485 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56664047 |
59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54974402 |
60 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53363795 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52728989 |
62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52403041 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51750265 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.51343382 |
65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50344600 |
66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49767883 |
67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48749921 |
68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45134938 |
69 | Measles_Homo sapiens_hsa05162 | 0.44277723 |
70 | Legionellosis_Homo sapiens_hsa05134 | 0.44061911 |
71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43823622 |
72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40641577 |
73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37452428 |
74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37006030 |
75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36633959 |
76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36312569 |
77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35174251 |
78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34932505 |
79 | Phagosome_Homo sapiens_hsa04145 | 0.33675674 |
80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32970347 |
81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32885245 |
82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31715573 |
83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31010132 |
84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30865821 |
85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30682126 |
86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28836012 |
87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28272542 |
88 | Apoptosis_Homo sapiens_hsa04210 | 0.26864333 |
89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26443396 |
90 | Peroxisome_Homo sapiens_hsa04146 | 0.25257437 |
91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.24159307 |
92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23780376 |
93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.22675464 |
94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22178890 |
95 | Shigellosis_Homo sapiens_hsa05131 | 0.21346467 |
96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21165981 |
97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19830263 |
98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19366580 |
99 | Protein export_Homo sapiens_hsa03060 | 0.18725312 |
100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.18718534 |